Disclosure Of Entity's Operating Segments [Text Block]

Oxford Biomedica PLC - Filing #5242757

Concept	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31
Disclosure of entity's operating segments [text block]	—	—	—		—	—	—	—	—	—	—	—	—
Disclosure of operating segments [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue	—	—	—	139, 989 GBP	—	—	—	—	—	—	—	142,797,000 GBP	—
Tax expense (income)	—	—	—	817,000 GBP	—	—	—	—	—	—	—	869,000 GBP	—
Profit (loss) before tax	—	—	—	45,976,000 GBP	—	—	—	—	—	—	—	19 ,880 GBP	—
Profit (loss)	– GBP	39,157,000 GBP	– GBP	45,159,000 GBP	– GBP	39 ,157 GBP	6, 002 GBP	– GBP	– GBP	– GBP	19 ,011 GBP	19, 011 GBP	19 ,011 GBP
Cash flows from (used in) operating activities	—	—	—	12, 615 GBP	—	—	—	—	—	—	—	25, 455 GBP	—
Cash flows from (used in) investing activities	—	—	—	56,462,000 GBP	—	—	—	—	—	—	—	9 , 461 GBP	—
Cash flows from (used in) financing activities	—	—	—	98,622,000 GBP	—	—	—	—	—	—	—	46,207,000 GBP	—
Disclosure of products and services [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]	—	—	—		—	—	—	—	—	—	—	—	—
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of major customers [abstract]
Disclosure of major customers [line items]